|
FY2026
12 months to Jan 3, 2026
|
FY2025
12 months to Dec 28, 2024
|
FY2024
12 months to Dec 30, 2023
|
FY2023
12 months to Dec 31, 2022
|
FY2022
12 months to Jan 1, 2022
|
|
|---|---|---|---|---|---|
| Operating activities | |||||
| Net earnings (loss) | |||||
| Net loss from discontinued operations | |||||
| Net earnings (loss) from continuing operations | |||||
| Items not affecting cash: | |||||
| Depreciation and amortization | |||||
| Amortization of debt issuance costs | |||||
| Deferred income taxes | |||||
| Stock-based compensation | |||||
| Impairment of property, plant and equipment | |||||
| Gain on sale of property, plant and equipment | |||||
| Gain on sale of smoothie bowls product line | |||||
| Loss on extinguishment of debt | |||||
| Other | |||||
| Changes in operating assets and liabilities, net of divestitures | |||||
| Net cash provided by operating activities of continuing operations | |||||
| Net cash provided by (used in) operating activities of discontinued operations | |||||
| Net cash provided by operating activities | |||||
| Investing activities | |||||
| Additions to property, plant and equipment | |||||
| Proceeds from sale of property, plant and equipment | |||||
| Additions to intangible assets | |||||
| Proceeds from sale of smoothie bowls product line | |||||
| Cash settlement of foreign currency forward contract | |||||
| Net cash used in investing activities of continuing operations | |||||
| Net cash provided by investing activities of discontinued operations | |||||
| Net cash provided by (used in) investing activities | |||||
| Financing activities | |||||
| Proceeds from notes payable | |||||
| Repayment of notes payable | |||||
| Net increase (decrease) in borrowings under revolving credit facilities | |||||
| Borrowings of short-term and long-term debt | |||||
| Repayment of short-term and long-term debt | |||||
| Proceeds from the exercise of stock options and employee share purchases | |||||
| Payment of withholding taxes on stock-based awards | |||||
| Repurchase of common shares | |||||
| Payment of cash dividends on preferred stock | |||||
| Repayment of asset-based credit facilities | |||||
| Payment of debt issuance costs | |||||
| Payment of common share issuance costs | |||||
| Payment of preferred stock issuance costs | |||||
| Net cash used in financing activities of continuing operations | |||||
| Net cash used in financing activities of discontinued operations | |||||
| Net cash used in financing activities | |||||
| Increase (decrease) in cash, cash equivalents and restricted cash in the period | |||||
| Balance at the beginning of the year | |||||
| Cash and cash equivalents, beginning of the year | |||||
| Cash and cash equivalents, end of the year | |||||
| Cash, cash equivalents and restricted cash, beginning of the year | |||||
| Cash, cash equivalents and restricted cash, end of the year | |||||
Loading...